No Data
No Data
Express News | HC Wainwright & Co. Reiterates Buy on ADC Therapeutics, Maintains $8 Price Target
Positive Buy Rating Driven by Promising ADC Therapeutics Trial and Financial Projections
ADC Therapeutics SA (NYSE:ADCT) Not Doing Enough For Some Investors As Its Shares Slump 35%
Is ADC Therapeutics SA (NYSE:ADCT) Worth US$2.0 Based On Its Intrinsic Value?
ADC Spikes After Enrollment Update on Confirmatory Trial for Lymphoma Therapy
ADC Completes Enrollment in Late-Stage Zynlonta Combination Trial
No Data